Hepatocellular carcinoma in a mouse model fed a choline-deficient, L-amino acid-defined, high-fat diet
- PMID: 28895242
- PMCID: PMC5639266
- DOI: 10.1111/iep.12240
Hepatocellular carcinoma in a mouse model fed a choline-deficient, L-amino acid-defined, high-fat diet
Abstract
Hepatocellular carcinoma (HCC) is a common cancer worldwide and represents the outcome of the natural history of chronic liver disease. The growing rates of HCC may be partially attributable to increased numbers of people with non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). However, details of the liver-specific molecular mechanisms responsible for the NAFLD-NASH-HCC progression remain unclear, and mouse models that can be used to explore the exact factors that influence the progression of NAFLD/NASH to the more chronic stages of liver disease and subsequent HCC are not yet fully established. We have previously reported a choline-deficient, L-amino acid-defined, high-fat diet (CDAHFD) as a dietary NASH model with rapidly progressive liver fibrosis in mice. The current study in C57BL/6J mice fed CDAHFD provided evidence for the chronic persistence of advanced hepatic fibrosis in NASH and disease progression towards HCC in a period of 36 weeks. When mice fed CDAHFD were switched back to a standard diet, hepatic steatosis was normalized and NAFLD activity score improved, but HCC incidence increased and the phenotype of fibrosis-associated HCC development was observed. Moreover, when mice continued to be fed CDAHFD for 60 weeks, HCC further developed without severe body weight loss or carcinogenesis in other organs. The autochthonous tumours showed a variety of histological features and architectural patterns including trabecular, pseudoglandular and solid growth. The CDAHFD mouse model might be a useful tool for studying the development of HCC from NAFLD/NASH, and potentially useful for better understanding pathological changes during hepatocarcinogenesis.
Keywords: choline deficiency; fibrosis; hepatocarcinogenesis; non-alcoholic steatohepatitis; spontaneous liver tumour model.
© 2017 The Authors. International Journal of Experimental Pathology published by John Wiley & Sons Ltd on behalf of Company of the International Journal of Experimental Pathology (CIJEP).
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5639266/bin/IEP-98-221-g001.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5639266/bin/IEP-98-221-g002.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5639266/bin/IEP-98-221-g003.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5639266/bin/IEP-98-221-g004.gif)
Similar articles
-
Nonalcoholic steatohepatitis-associated hepatocarcinogenesis in mice fed a modified choline-deficient, methionine-lowered, L-amino acid-defined diet and the role of signal changes.PLoS One. 2023 Aug 3;18(8):e0287657. doi: 10.1371/journal.pone.0287657. eCollection 2023. PLoS One. 2023. PMID: 37535625 Free PMC article.
-
A Comparison of the Gene Expression Profiles of Non-Alcoholic Fatty Liver Disease between Animal Models of a High-Fat Diet and Methionine-Choline-Deficient Diet.Molecules. 2022 Jan 27;27(3):858. doi: 10.3390/molecules27030858. Molecules. 2022. PMID: 35164140 Free PMC article. Review.
-
Comparison of murine steatohepatitis models identifies a dietary intervention with robust fibrosis, ductular reaction, and rapid progression to cirrhosis and cancer.Am J Physiol Gastrointest Liver Physiol. 2020 Jan 1;318(1):G174-G188. doi: 10.1152/ajpgi.00041.2019. Epub 2019 Oct 21. Am J Physiol Gastrointest Liver Physiol. 2020. PMID: 31630534 Free PMC article.
-
Nonalcoholic fatty liver disease and hepatocellular carcinoma.Metabolism. 2016 Aug;65(8):1151-60. doi: 10.1016/j.metabol.2016.01.010. Epub 2016 Jan 23. Metabolism. 2016. PMID: 26907206 Review.
-
MicroRNA expression analysis in high fat diet-induced NAFLD-NASH-HCC progression: study on C57BL/6J mice.BMC Cancer. 2016 Jan 5;16:3. doi: 10.1186/s12885-015-2007-1. BMC Cancer. 2016. PMID: 26728044 Free PMC article.
Cited by
-
Periportal macrophages protect against commensal-driven liver inflammation.Nature. 2024 May;629(8013):901-909. doi: 10.1038/s41586-024-07372-6. Epub 2024 Apr 24. Nature. 2024. PMID: 38658756
-
A Mouse Model of Non-Alcoholic Steatohepatitis and Hepatocellular Carcinoma Induced by Western Diet and Carbon Tetrachloride.Methods Mol Biol. 2024;2769:57-65. doi: 10.1007/978-1-0716-3694-7_4. Methods Mol Biol. 2024. PMID: 38315388
-
Acanthopanax senticosus ameliorates steatohepatitis through HNF4 alpha pathway activation in mice.Sci Rep. 2024 Jan 2;14(1):110. doi: 10.1038/s41598-023-50625-z. Sci Rep. 2024. PMID: 38167633 Free PMC article.
-
New and Old Key Players in Liver Cancer.Int J Mol Sci. 2023 Dec 5;24(24):17152. doi: 10.3390/ijms242417152. Int J Mol Sci. 2023. PMID: 38138981 Free PMC article. Review.
-
Phospholipid isotope tracing reveals β-catenin-driven suppression of phosphatidylcholine metabolism in hepatocellular carcinoma.bioRxiv [Preprint]. 2023 Oct 16:2023.10.12.562134. doi: 10.1101/2023.10.12.562134. bioRxiv. 2023. Update in: Biochim Biophys Acta Mol Cell Biol Lipids. 2024 Aug;1869(6):159514. doi: 10.1016/j.bbalip.2024.159514. PMID: 37904922 Free PMC article. Updated. Preprint.
References
-
- Abanobi S.E., Lombardi B. & Shinozuka H. (1982) Stimulation of DNA synthesis and cell proliferation in the liver of rats fed a choline‐devoid diet and their suppression by phenobarbital. Can. Res. 42, 412–415. - PubMed
-
- Abelev G.I. & Eraiser T.L. (1999) Cellular aspects of alpha‐fetoprotein reexpression in tumors. Semin. Cancer Biol. 9, 95–107. - PubMed
-
- Angulo P., Keach J.C., Batts K.P. & Lindor K.D. (1999) Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 30, 1356–1362. - PubMed
-
- Bruix J., Sherman M. & Practice Guidelines Committee A.A.f.t.S.o.L.D. (2005) Management of hepatocellular carcinoma. Hepatology 42, 1208–1236. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical